NCCN Launches 3D Virtual Simulator Learning Platform
Contact Our Team
For more information about how Halldale can add value to your marketing and promotional campaigns or to discuss event exhibitor and sponsorship opportunities, contact our team to find out more
The Americas -
holly.foster@halldale.com
Rest of World -
jeremy@halldale.com
The National Comprehensive Cancer Network® (NCCN®) has launched a 3D Virtual Metastatic Colorectal Cancer (mCRC) Simulator Learning Platform as part of the NCCN Continuing Education Program.
NCCN collaborated with Syandus, Inc., a technology company specializing in the development of experiential learning platforms for health care professionals and other learners to develop the 3D Virtual mCRC Simulator Learning platform.
Robert Carlson, MD, Chief Executive Officer of NCCN says the platform is a virtual, three-dimensional, real-world vision that provides participants with an engaging and self-correcting learning atmosphere" and is based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Colon and Rectal Cancers.
The simulator lets users virtually work through the continuum of care approach to colorectal cancer in a risk-free environment with increasingly complex clinical presentations, and features new clinical data and emerging agents. It tracks progress throughout the simulation scenarios as users go through the steps of treating virtual patients – providing immediate feedback on clinical choices and an opportunity to reflect and revise approaches to treatment. Users who successfully complete eight scenarios will earn a certificate and three continuing education credits. This education is provided at no cost to learners.
Principal faculty for the simulator are the Chair and Vice-Chair of the NCCN Guidelines® Panels for Colon and Rectal Cancers, Al B. Benson, III, MD, FACP, FASCO, Professor of Medicine at Northwestern University Feinberg School of Medicine, and Associate Director for Clinical Investigations at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and Alan P. Venook, MD, The Madden Family Distinguished Professor of Medical Oncology and Translational Research, UCSF Helen Diller Family Comprehensive Cancer Center, respectively.
NCCN is currently working on a virtual learning platform for multiple myeloma that it expects to launch in 2015.
NCCN is a non-profit alliance of 25 of the world's leading cancer centers dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. It promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians and other health care decision-makers.
